1,000
Participants
Start Date
June 15, 2022
Primary Completion Date
June 15, 2025
Study Completion Date
June 15, 2026
ctDNA, tumor NGS
Testing for actionable oncogenic drivers
RECRUITING
NYU, New York
RECRUITING
Columbia University, New York
RECRUITING
Virginia Cancer Specialists, PC, Fairfax
RECRUITING
Medical University of South Carolina, Charleston
RECRUITING
Moffitt Cancer Center, Tampa
RECRUITING
Ohio State University, Columbus
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Northwestern University, Chicago
RECRUITING
Washington University, St Louis
RECRUITING
University of Missouri, Columbia
RECRUITING
Baylor College of Medicine, Houston
RECRUITING
USC Norris Comprehensive Cancer Center, Los Angeles
RECRUITING
UCLA, Los Angeles
RECRUITING
St. Joseph's Hospital Orange, Orange
RECRUITING
University of California, Davis, Davis
RECRUITING
University of Washington, Seattle
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Brigham and Women's Hospital, Boston
RECRUITING
Boston Medical Center, Boston
RECRUITING
Dana-Farber Cancer Institute, Boston
RECRUITING
Dartmouth-Hitchcock, Lebanon
Collaborators (1)
Lung Cancer Research Foundation
OTHER
Lung Cancer Mutation Consortium
NETWORK